ARK Genomic Revolution ETF vs Lufax Holding Ltd — how do they compare? ARK Genomic Revolution ETF trades at $44.79, while Lufax Holding Ltd trades at $1.54 (market cap $2.41B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Lufax Holding Ltd nearer its low. Which is the better fit depends on your goals.
| ARKG | LU | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $4.40 |
52-Week Low | $24.02 | $1.23 |
Market Cap | — | $2.41B |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →